In industrialized countries, osteoporosis is one of the most common diseases of the musculoskeletal system.
According to the Austrian Osteoporosis Report, about 740,000 people over the age of 50 are affected in Austria, 617,000 are women. About 16,500 people suffer a hip fracture every year. Preventing osteoporotic fractures means preventing personal suffering and saving costs. Bisphosphonates, along with calcium and vitamin D supplementation, physical training and fall prevention, are the standard first-line therapy for osteoporosis. They have demonstrated antifracture efficacy and are those agents that have proven most effective in the treatment of postmenopausal osteoporosis.1
1 Preisinger E. et al. Management of osteoporosis. ÖAZ, 2012, 20: 24-35.